Advice
Following a full submission
Metformin (Glucophage SR®) is not recommended for use within NHS Scotland for the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone do not result in adequate glycaemic control.
Metformin (Glucophage SR) did not demonstrate any benefits in efficacy or side effect profile over the immediate release metformin and is considerably more expensive.
Download detailed advice41KB (PDF)
Medicine details
- Medicine name:
- Metformin hydrochloride (Glucophage SR®)
- SMC ID:
- 148/04
- Indication:
- Type-2 diabetes mellitus
- Pharmaceutical company
- Merck Serono Ltd
- BNF chapter
- Endocrine system
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 07 March 2005